Research & Development

The New England Journal of Medicine (NEJM) has published positive results from two pivotal, multi-centre, Phase III studies –AMAGINE-2 and...

AstraZeneca and Eli Lilly and Company (Lilly) today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies...

Eli Lilly and Company (NYSE: LLY) and the ACCELERATE study's academic leadership have accepted the recommendation of the independent data...

Allergan plc (NYSE: AGN), a leading global specialty pharmaceutical company, today announced a multi-year research collaboration with Humana Inc. (NYSE:...

We were pioneers among Indian pharmaceutical companies to see tremendous value in investing in research & development (R&D). Our early...

In addition to ensuring that Amgen's investment decisions are based on compelling science, we are reengineering our processes to operate...

At Amgen, we believe drug discovery starts with a deep understanding of biology. This understanding guides the critical choice of...

At a time when technological breakthroughs are revolutionizing how drugs are discovered, Amgen's strategy aims to fully exploit the emerging...

Many companies in our industry have pursued a strategy known as "Shots on Goal," where the aim is to maximize...

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, and Boehringer Ingelheim (BI) announced today that they have...